The world's top ten research and development institutions released, the Chinese Academy of Sciences ranked third, the United States accounted for 7 seats!

Guide: Recently, a research institute used the Nature Index to rank the world's top research and development institutions.
translational science is the process of using biomedical research results (preclinical and early clinical) to support drug development and is the backbone of biomedical research, often in academic and research and development institutions.
without these research institutions, many new drugs and diagnostics would be difficult to come by.
they are more likely to be involved in diseases with limited commercial prospects than in traditional areas such as cancer.
biopharmaceutical companies often have heavy responsibilities in late-stage clinical trials and production, the work of these research institutions still requires significant financial support.
2018, total U.S. investment in health care research and development was $194.2 billion, according to a report by the company.
: Companies invested $129.5 billion (66.7 percent) in health care research and development, federal agencies $43 billion (22.2 percent) and academic and research institutions invested $15.7 billion (8.1 percent).
growth rate of medical and health research and development investment exceeded the growth rate of total health expenditure for three consecutive years.
, research and development still accounts for only about 5% of health spending.
recently, a research institute used the Nature Index to rank the world's top research and development institutions.
natural indices use paper counts (AC) and fractional counts (FCs) to calculate research results.
55 of the 82 journals included in the Nature Index were counted, and the following are the top 10 they used this method and their scores: 1. Harvard University: 2,312.652. National Institutes of Health (NI) H): 1,332.543.Cas:1,034.324.Stanford University: 1,027.415.Max Planck Institute: 991.1 326. University of California, San Francisco (UCSF): 754.287.Yale University: 748.58. University of Pennsylvania (Penn): 687.759.UC San Diego 680.7510 Oxford University: 670.64 1. Harvard University is often synound for prestige, and its greatest advantage is Harvard Medical School, which has many of the world's greatest experts in the field of life sciences, such as Aviv Regev.
Aviv Regev, one of the bulls in computational biology, pioneered the measurement of single-cell RNA sequencing and did pioneering work on machine learning algorithms for extracting biological information.
May, Roche announced that Aviv Regev would join Genentech as the new head of Genentech Research and Early Development.
biopharmaceutical companies have long valued Harvard's technology and insights.
, researchers at Harvard University teamed up with Japanese pharmaceutical company Astellas to focus on the development of innovative therapies and technologies of common interest.
addition, Bayer and Morningside Ventures led a $28.5 million round of financing for Vesigen Therapeutics in July.
Vesigen will use the funds raised to build the ARMMS platform, using proprietary delivery technologies to overcome barriers to the delivery of next-generation therapies such as CRISPR-cas9, RNA molecules and other therapeutic proteins within targeted cells.
and will drive a wide range of therapeutic media into preclinical and clinical development.
. The National Institutes of Health (NIH), with nearly $40 billion in funding, is the most well-funded research and development institution in the United States, second only to Harvard University on this list.
10 per cent of the NIH's budget is used to support projects carried out by nearly 6,000 scientists in their laboratories.
all of this adds up, making it not only the largest biomedical research institution in the United States, but also the world's largest public funder of biomedical research.
with the COVID-19 crisis, the importance of its funding has become particularly important this year.
NIH has been at the forefront of antiviral research, working with and funding vaccine leader Moderna and many other biopharmaceutical companies for vaccine, diagnostic and treatment studies against COVID-19.
Chinese Academy of Sciences (CAS), which ranks third this time, is climbing rapidly, even though the top two research and development institutions are located in the United States.
Since the founding of the Chinese Academy of Sciences in 1949, it now has 12 institutes, more than 100 research institutes, 3 universities, more than 130 national key laboratories and engineering centers, more than 270 field observatories, and has undertaken the construction and operation of more than 20 major national scientific and technological infrastructure.
has participated in a number of important studies in the rapid response of CAS after the outbreak of coronary pneumonia.
, the Institute of Microbiology of the Chinese Academy of Sciences, in cooperation with Junshi Bio, developed the new coronavirus and antibody JS016.
July, JS016 had completed all subjects to phase I clinical trials in China.
April, the Wuhan Institute of Virus Research of the Chinese Academy of Sciences, in cooperation with the Wuhan Institute of Biological Products of the National Pharmaceutical Group, obtained approval for phase I and II clinical trials through the special approval procedures of the State Drug Administration.
, the new coronavirus inactivated vaccine product is the world's first inactivated vaccine to be approved for clinical trials to enter Phase III clinical trials.
addition, the recombination of the new coronavirus vaccine (CHO cells) developed by the Institute of Microbiology of the Chinese Academy of Sciences in collaboration with Zhifei Bio-owned subsidiary Zhifeilong Coma is currently in the process of phase I., II. clinical trials.
reference source 1.